Related Experiment Videos
[Cutaneous side effects of medical tumor therapy]
1Klinik für Dermatologie, Allergologie und Venerologie, Hauttumorzentrum Hannover (HTZH), Medizinische Hochschule Hannover. degen.annette@mh-hannover.de
Abstract:
Agents used in medical tumor therapies can cause peculiar cutaneous side effects. In particular the newly developed targeted therapies are associated with specific cutaneous side effects, such as a papulopustular exanthems associated with EGFR inhibitors and epithelial skin cancers associated with inhibitors of mutated BRAF. In this review the clinical pictures as well as pathogenetic and therapeutic aspects of the hand-foot-syndrome, papulopustular exanthems, epithelial skin cancers, paronychia and changes of hair and nails as side effects of medical tumor therapies are summarized. Knowledge of these side effects is important to avoid interruption or termination of the tumor therapy, in particular since some of the cutaneous reactions have been shown to correlate with the therapeutic benefit of the tumor therapy.
Insights
Medical tumor therapies can cause unique skin side effects like hand-foot syndrome and papulopustular exanthems. Recognizing these cutaneous reactions is crucial for continuing effective cancer treatment.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Context:
- Medical tumor therapies, especially novel targeted agents, are linked to specific dermatological adverse events.
- EGFR inhibitors can cause papulopustular exanthems, while BRAF inhibitors are associated with epithelial skin cancers.
Purpose:
- To review the clinical presentation, pathogenesis, and management of common cutaneous side effects from cancer therapies.
- To highlight the importance of identifying and managing these skin reactions to ensure treatment continuity.
Summary:
- This review details hand-foot syndrome, papulopustular exanthems, epithelial skin cancers, paronychia, and hair/nail changes as side effects of medical tumor therapies.
- It covers their clinical features, underlying mechanisms, and therapeutic strategies.
Impact:
- Early recognition and management of these cutaneous side effects can prevent treatment interruption or discontinuation.
- Some skin reactions correlate with improved therapeutic benefit, underscoring their clinical significance.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...